Tag: respiratory syncytial virus

Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children

Saleh al-Alaiyan, Paul Pollack, Gerard F Notario

Article Type

Case Report

Published

The peak season of respiratory syncytial virus (RSV) infections in warmer climates may extend beyond the typical five-month RSV season of temperate regions. This study aimed to assess the safety, immunogenicity, and pharmacokinetics of an extended seven-dose regimen of palivizumab in children at high risk for serious infection by the RSV.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.